1.
J Paediatr Child Health
; 58(1): 201-202, 2022 Jan.
Article
in English
| MEDLINE
| ID: mdl-34060675
Subject(s)
COVID-19 , COVID-19/complications , Child , Humans , Pediatricians , SARS-CoV-2 , Surveys and Questionnaires , Post-Acute COVID-19 Syndrome
2.
Infez Med
; 27(2): 194-197, 2019 Jun 01.
Article
in English
| MEDLINE
| ID: mdl-31205046
ABSTRACT
Drug-induced aseptic meningitis (DIAM) represents a diagnostic challenge since clinical and cerebrospinal fluid (CSF) findings may be indistinguishable from a bacterial meningitis. Intravenous immunoglobulin (IVIg) are commonly used in a variety of diseases, including inflammatory and autoimmune disorders. Although usually well-tolerated, various adverse effects have been reported. DIAM is a serious neurological side effect of IVIg therapy: albeit rare (0.067% of all IVIg infusions), the condition represents an important diagnostic challenge and should be considered by physicians. Here we report a case of an aseptic meningitis induced by IVIg therapy in a child with acute Epstein-Barr virus (EBV) infection and thrombocytopenia.